28 March 2024 : Clinical Research
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
Mustafa Karaca



DOI: 10.12659/MSM.943750
Med Sci Monit 2024; 30:e943750
Table 5 Factors associated with poor pathologic response.
Variables | OR (95% CI) | p |
---|---|---|
Age | 0.959 (0.932–0.988) | |
Male gender | 1.194 (0.625–2.284) | 0.591 |
Comorbid disease | 1.664 (0.875–3.167) | 0.121 |
Chemotherapy agent | ||
Capecitabine | Reference | – |
5-FU | 1.239 (0.663–2.317) | 0.501 |
NLR at diagnosis >3.63 | 2.595 (1.229–5.478) | |
OR – odds ratio; CI – confidence interval; 5-FU – 5-Fluorouracil; NLR – neutrophil/lymphocyte ratio. |